GDS Holdings Ltd

GDHLF

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Driehaus Capital

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 51,576Value: $1.8M

# Signal Note: Driehaus Capital Initiates GDS Holdings Position **Summary:** Driehaus Capital's $1.8M entry into GDS Holdings (GDHLF), a clinical-stage biotech, signals conviction in the firm's pipeline despite growth sector headwinds. Without specifics on GDS's lead program (indication, development stage, competitive positioning), the timing suggests either recent positive trial data, upcoming catalysts, or valuation inflection that attracted a growth-focused allocator with established biotech expertise. **Note:** GDS Holdings' clinical pipeline details would be needed to assess catalyst proximity and commercial risk profile.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: